Hereditary cancers account for only about 5 percent of all malignancies. Nevertheless, it is very important to recognize these individuals and their family members because, unlike patients with sporadic cancers, they require long-term specific clinical care to permit early detection and/or risk reduction measures.
This application note discusses the prevalence and causative mutations of several hereditary cancer syndromes, as well as the benefits of next-generation sequencing for hereditary cancer as compared to single-gene testing.
Offered Free by: Qiagen
See All Resources from: Qiagen
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.